Today was a dream come true. This was the one I was hoping for. I now have no doubt that Neuren have a platform, which WILL fulfill unmet needs in rare and debilitating neurological conditions and likely in the broader autism spectrum.
Believing in that is my celebration. Financially, who knows where we are headed (apart from directionally upwards). Business wise, who knows where we are headed, but if/when control is relinquished it will have been one hell of a journey.
Congratulations to Dame Margaret, to management past and present and to all long termers who have lasted and believed through the highs and lows.
Nothing will stop us now.
Ann: P2 trial shows significant improvements in Phelan-McDermid, page-186
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.26 |
Change
-0.280(2.23%) |
Mkt cap ! $1.525B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $6.952M | 570.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 231 | $12.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.32 | 1979 | 2 |
View Market Depth
| Last trade - 16.13pm 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |